Organon (OGN) Shares Outstanding (Weighted Average) (2020 - 2025)
Organon has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $259.5 million for Q4 2025.
- Quarterly results put Shares Outstanding (Weighted Average) at $259.5 million for Q4 2025, up 0.95% from a year ago — trailing twelve months through Dec 2025 was $259.5 million (up 0.95% YoY), and the annual figure for FY2025 was $259.5 million, up 0.95%.
- Shares Outstanding (Weighted Average) for Q4 2025 was $259.5 million at Organon, roughly flat from $259.3 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for OGN hit a ceiling of $259.9 million in Q2 2025 and a floor of $253.5 million in Q1 2021.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $255.0 million (2023), compared with a mean of $255.6 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): changed 0.0% in 2021 and later increased 1.34% in 2025.
- Organon's Shares Outstanding (Weighted Average) stood at $253.5 million in 2021, then increased by 0.21% to $254.1 million in 2022, then rose by 0.46% to $255.2 million in 2023, then grew by 0.71% to $257.0 million in 2024, then grew by 0.95% to $259.5 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $259.5 million (Q4 2025), $259.3 million (Q3 2025), and $259.9 million (Q2 2025) per Business Quant data.